References

Cure Arthritis Naturally

Cure Arthritis Naturally

Get Instant Access

Alarcon-Segovia D, Babb RR, Fairbairn JF (1963) Systemic lupus erythematosus and ery-

thromyalgias. Ann Intern Med 112:102-106 Aoki T, Ishizawa T, Hozumi Y, Aso K, Kondo S (1996) Chilblain lupus erythematosus of Hutchinson responding to surgical treatment: a report of two patients with anti Ro/SS-A antibodies. British J Dermatol 134:533-537 Bielsa I, Herrero C, Font J, Mascaro JM (1987) Lupus erythematosus and toxic epidermal necro-

lysis. J Am Acad Dermatol 16:1265-1267 Boire G, Menard HA, Gendron M, Lussier A, Myhal D (1993) Rheumatoid arthritis: anti Ro antibodies define a non HLA-DR4 associated clinical serological cluster. J Rheumatol 20:1654-1660

Boire G, Menard HA (1988) Clinical significance of anti-Ro (SS-A) antibody in rheumatoid arthritis. J Rheumatol 15:391-394 Callen J, Ross L (1981) Subacute cutaneous lupus in porphyria cutanea tarda. J Am Acad Derma-tol 5:269-273

Chorzelski T, Jablonska S, Blasczyk M (1968) Immunopathological investigations in the Senear Usher syndrome (coexistence of pemphigus and lupus erythematosus). Br J Dermatol 80:211-217

Clemmenson O, Thomasen K (1982) Porphyria cutanea tarda in systemic lupus erythematosus.

Arch Dermatol 118:160-162 Cohen JS (2000) Erythromelalgia: new theories and new therapies. J Am Acad Dermatol 43:841-847

Cohen S, Stastny P, Sontheimer RD (1986) Concurrence of subacute cutaneous lupus erythe-

matosus and rheumatoid arthritis. Arthritis Rheum 29:421-425 Collier DH, Lee LA (2000) Three generations of patients with lupus erythematosus and hereditary angioedema.Am J Med 109:256-257 Cram DL, Epstein JH, Tuffanelli DL (1973) Lupus erythematosus in porphyria: coexistence in 7

patients. Arch Dermatol 108:779-784 Cribier B, Djeridi N, Peltre B, Grosshans E (2001) A histologic and immunohistochemical study of chilblains. J Am Acad Dermatol 45:924-929 Cruz PD Jr, Colison BM, Sontheimer RD (1987) Concurrent features of cutaneous lupus erythe-

matosus following myosthenia gravis and thymoma. J Am Acad Dermatol 16:472-480 DeBracco MM, Bianchi CA, Bianchi O (1979) Hereditary complement (C2) deficiency with discoid lupus erythematosus and idiopathic anetoderma. Int J Dermatol 18:713-717 Diment J, Ginzler E, Schleisinger M, Sterba G, Diamond H, Kaplan D,Weiner M (1979) The clinical significance of Raynauds phenomenon in systemic lupus erythematosus. Arthritis 22:815-819

Dubois EL, Tuffanelli DL (1964) Clinical manifestations of systemic lupus erythematosus. JAMA 190:104-107

Estes D, Christian CL (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine 50:85-95 Euwer RL, Sontheimer RD (1991) Amyopathic dermatomyositis (dermatomyositis sine myositis). J Am Acad Dermatol 24:959-966 Franceschini F, Calzavara-Pinton P, Quinzanini M, Cavazzana I, Bettoni L, Zane C, Faccheti F, Airo P, McCauliffe DP, Cattanes R (1999) Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. Lupus 8:215-219 Gammon WR, Briggaman RA (1993) Bullous SLE: a phenotypically distinctive but immunologic heterogeneous bullous disorder. J Invest Dermatol 100:28S-34S Gammon WR, Woodley D, Dole KC, Briggaman RA (1985) Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epi-dermolysis bullosa acquisita autoantigen. J Invest Dermatol 84:472-476 Gilliam JM, Cohen SB, Sontheimer RD, Moscella SL (1985) Connective tissue diseases. In:

Moscella SL, Hurley HJ (eds) Dermatology,WB Saunders, Philadelphia, 1087-1135 Hall RP, Lawley TJ, Smith HR, Katz SI (1982) Bullous eruption of systemic lupus erythematosus.

Ann Intern Med 97:165-170 Hochberg MC, Boyd RB,Ahearn JM,Arnett FC, Bias WB, Provost TT, Stevens MB (1985) Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographics subsets. Medicine 64:285-295 Kabir JDI, Malkinson FD (1969) Lupus erythematosus and calcinosis cutis. Arch Dermatol 100:17-22

Kallenberg CS, Wouda AA, The TH (1980) Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon. Am J Med 69:675-680 Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV (1995) The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 332:993-997 Kohler PF, Percy J, Campion WM, Smyth CJ (1974) Hereditary angioedema and "familial" lupus erythematosus in identical twin bodies. Am J Med 56:406-411 Kuhn A, Sonntag M, Richter-Hintz D, Oslislo C, Megahed M, Ruzicka T, Lehmann P (2001) Pho-

totesting in lupus erythematosus: a 15 year experience. J Am Acad Dermatol 45:86-95 Levine JS (2002) The antiphospholipid syndrome. N Eng J Med 346:752-763 Levine SR, Langer SL, Albers JW, Welch KMA (1988) Sneddon's syndrome: an antiphospholipid antibody syndrome. Neurology 38:798-800 Maddison PJ, Mogavero H, Reichlin M (1978) Patterns of clinical disease associated with antibodies to nuclear ribonucleo protein. J Rheumatol 5:407-411 Maruyama M, Miyaychi S, Hashimoto K (1997) Massive cutaneous mucinosis associated with systemic lupus erythematosus. Br J Dermatol 137:450-453 Millard LG, Rowell NR (1978) Chilblain lupus erythematosus (Hutchinson). Br J Dermatol 98:497-506

Mond CB, Peterson MGE, Rothfield NF (1989) Correlation of anti-Ro antibody with photosensi-

tivity rash in systemic lupus erythematosus patients. Arthritis Rheum 32:202-204 Nishikawa T, Provost TT (1991) Difference in clinical serological and immunogenetic features of White versus Oriental anti-Ro (SS-A) antibody positive patients. J Am Acad Dermatol 25:563-564

O'Laughlin S, Schroeter AL, Jordon RE (1978) Chronic urticaria-like lesions in systemic lupus erythematosus. Arch Dermatol 114:879-883 Pistiner M, Wallace DJ, Nessim S, Metzger AL (1991) Lupus erythematosus in the 1980's: a survey of 570 patients. Semin Arthritis Rheum 21:55-64 Provost TT, Watson R, Simmons-O'Brien E (1996) Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease. J Am Acad Dermatol 35:147-169 Provost TT, Watson RM, Gammon WR, Reichlin M (1987) The neonatal lupus syndrome associated with U1RNP antibodies. N Eng J Med 316:1135-1138 Provost TT, Zone JJ, Synkowski DL, Maddison PJ, Reichlin M (1980) Unusual cutaneous manifestation of systemic lupus erythematosus: urticarial-like lesions. J Invest Dermatol 75:495-499

Randle HW, Muller S (1983) Generalized elastolysis associated with systemic lupus erythematosus. J Am Acad Dermatol 8:869-873 Rendon MI, Cruz PD, Sontheimer RD, Bergstresser RD (1989) Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin. J Am Acad Dermatol 21:461-469 Roubey RAS (1996) Immunology of antiphospholipid syndrome.Arthritis Rheum 39:1444-1454 Rowell NR, Swanson-Beck J, Anderson JR (1963) Lupus erythematosus and erythema multi-

forme-like lesions. Arch Dermatol 88:176-180 Ruzicka T, Faes J, Bergner T (1991) Annular erythema associated with Sjogren's syndrome: a variant of systemic lupus erythematosus. J Am Acad Dermatol 25:557-560 Sharp GC, Irvin WS, May CM (1976) Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective tissue disease systemic lupus erythematosus and other rheumatic diseases. N Engl J Med 295:1149-1154 Shu U, Mannik M (1988) Low molecular weight C1q binding immunoglobulin G in patients with systemic lupus erythematosus consists of antibodies to collagen-like region of C1q. Clin Invest 82:816-820

Simmons-O'Brien E, Chen S,Watson R, Provost TT (1995) 100 anti-Ro (SS-A) antibody positive patients: a ten year follow up. Medicine 74:109-130 Sneddon IB (1965) Cerebro-vascular lesions and livedo reticularis. Br J Dermatol 77:180-185 Sontheimer RD, Provost TT (1996) Lupus erythematosus. In: Sontheimer RD, Provost TT (eds)

Cutaneous manifestations of rheumatic diseases. Williams & Wilkins, Baltimore, pp 1-71 Stonecipher MR, Jorrigo JL, White WL, Walker FO (1993) Cutaneous changes of dermatomyosi-tis in patients with normal enzymes: dermatomyositis sine myositis. J Am Acad Dermatol 28:951-956

Teramato N, Katayama A, Arai H (1989) Annular erythema: a possible association with primary

Sjogren's syndrome. J Am Acad Dermatol 20:596-601 Trendelenburg M, Courvoisier S, Späth PJ, Moll S, Mihatsch M, Itin P, Schifferli JA (1999) Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus. Am J Kidney Dis 34:745-751

Urowitz MB, Gladmann DD, Chalmers A, Ogryzlo MA (1978) Nail lesions in systemic lupus ery-

thematosus. J Rheumatol 5:441-447 van der Horst JC, Cirkel PKS, Niebore C (1983) Mixed lichen planus - lupus erythematosus disease - a distinct entity? Clinical, histopathologic, and immunopathological studies in 6 patients. Clin Exp Dermatol 8:631-640 Vaughn RY, Bailey JP Jr, Field RS, Loebl DH, Mealing HG Jr, Jerath RS, Dorlon RE (1990) Diffuse nail dyschromia in black patients with systemic lupus erythematosus. J Rheumatol 16: 640-643

Viguier M, Pinqirier L, Cavelier-Balloy B, Salmoniere P, Cordoliani F, Flageul B, Morel P, Dubertrt L, Bachelez H (2001) Clinical and histopathologic features and immunologic variables in patients with severe chilblains: a study of the relationship to lupus erythematosus. Medicine 80:180-188

Watanbe T, Tsuchida T, Ito Y, Kanda N, Ueda Y, Tamaki K (1997) Annular erythema associated with lupus erythematosus/Sjogren's syndrome. J Am Acad Dermatol 36:214-218 Weatherhead L, Adam J (1985) Discoid lupus erythematosus: coexistence with porphyria cutanea tarda. Int J Dermatol 108:453-455 Wisnieski JJ, Jones SM (1992) Comparison of autoantibodies to collagen-like region of C1q in hypcomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol 148:1396-1403 Yasue T (1986) Lividoid vasculitis and central nervous system involvement in systemic lupus erythematosus. Arch Dermatol 122:66-70

CHAPTER 8

Was this article helpful?

0 0
Osteoarthritis

Osteoarthritis

Thank you for deciding to learn more about the disorder, Osteoarthritis. Inside these pages, you will learn what it is, who is most at risk for developing it, what causes it, and some treatment plans to help those that do have it feel better. While there is no definitive “cure” for Osteoarthritis, there are ways in which individuals can improve their quality of life and change the discomfort level to one that can be tolerated on a daily basis.

Get My Free Ebook


Post a comment